As per the research report, the size of the North America Hormone Replacement Therapy Market Size is valued at USD 7.25 billion in 2022 and is predicted to reach USD 10.23 billion by 2027, growing at a CAGR of 7.12% during the forecast period 2022 to 2027.
The rise in the incidence of the menopausal disorder and increased awareness of postmenopausal difficulties among women are two significant factors driving the North American hormone replacement therapy market forward. In addition, new hormone replacement treatment launches are expected to impact the hormone replacement therapy market growth substantially. Shortly, the introduction of bioidentical hormone replacement treatment, increase in the occurrences of hormone imbalance diseases in the elderly, neonatal populations, and the use of telemedicine for hormone replacement therapy are projected to give lucrative growth for the North American hormone replacement therapy market to grow.
Furthermore, prominent manufacturers' intensive marketing and direct selling activities, rising consumer awareness, routinely monitored formulations, and the development of novel gel-based formulations have created a demand for the market. The woman's body goes through a lot of hormonal changes. In addition, hormone levels fluctuate as people age, resulting in a variety of problems and diseases. Furthermore, rising product approvals and increasing R&D activity by crucial players to discover novel therapies to treat hormonal imbalances, technological improvements in drug delivery systems, and frequently monitored formulations are likely to aid in the positive expansion of the market throughout the forecast period. In addition, menopausal women make up a significant portion of the demand.
During the forecast period, unfavorable effects of hormone replacement therapy and high treatment costs are expected to restrict market expansion. Along with this, the risk of acquiring cancer from HRTs is expected to limit North American market growth.
This research report on the North America Hormone Replacement Therapy Market has been segmented and sub-segmented into the following categories:
By Hormone Type:
By Route of Administration:
Geographically, the North America dominated the global hormone replacement therapy market in 2020 in terms of revenue share. North America's dominance is likely to be maintained over the forecast period due to drug delivery system innovation, the development of novel formulations, and a growing target population. According to the National Institutes of Health, half of the postmenopausal women have used HRT once.
Increased awareness of postmenopausal concerns, increased medication research with novel delivery technologies, and hormonal imbalance disorders with the growing elderly population are all factors that are positively driving the hormone replacement therapy (HRT) market growth.
Because of the United States market, North America continues to be the most lucrative area in the global hormone replacement treatment market. Increasing incidences of hypothyroidism, hypogonadism, and other growth hormone shortages, as well as a growing number of newborns, are predicted to boost demand over the forecast period. In addition, the need for HRT in North America is increasing due to an increase in the frequency of hormone imbalance illnesses, particularly in the geriatric populations.
Health Canada has licensed HRT medications to treat menopausal symptoms such as night sweats, hot flashes, and vaginal dryness and prevent osteoporosis. Several women have been prescribed estrogen with or without progestin HRT to alleviate menopause symptoms.
KEY MARKET PARTICIPANTS
Companies playing a dominant role in the North America Hormone Replacement Therapy Market profiled in this report are Novartis, Abbott Laboratories, Pfizer, Mylan Laboratories, F. Hoffmann-La Roche, Merck & Co, Amgen, Eli Lily, Bayer, Novo Nordisk, Wyeth, Hisamitsu Pharmaceutical Co. Inc.,
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Hormone Type
5.1.1 Estrogen Replacement Therapy
5.1.2 Growth Hormone Replacement Therapy
5.1.3 Thyroid Replacement Therapy
5.2 By Route of Administration
6. Geographical Analysis
6.2 United States
7. Pipeline Product Analysis
7.2 Pipeline Development Landscape
7.3 Molecular Targets in the Pipeline
7.4 Clinical Trials
7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target
7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target
7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.
8.1 PESTLE analysis
8.2 Porter’s Five analysis
8.2.1 Bargaining Power of Suppliers
8.2.2 Bargaining Power of Consumers
8.2.3 Threat of New Entrants
8.2.4 Threat of Substitute Products and Services
8.2.5 Competitive Rivalry within the Industry
9.Market Leaders' Analysis
9.1 Abbott Laboratories
9.1.2 Product Analysis
9.1.3 Financial analysis
9.1.4 Recent Developments
9.1.5 SWOT analysis
9.1.6 Analyst View
9.4 Mylan Laboratories
9.6 Merck & Co.
9.8 Eli Lily & Company
9.9 Novo Nordisk
9.11 F. Hoffmann-La Roche
9.12 Hisamitsu Pharmaceutical Co. Inc.
10.1 Market share analysis
10.2 Merger and Acquisition Analysis
10.3 Agreements, collaborations and Joint Ventures
10.4 New Product Launches
11.1 Market Outlook
11.2 Investment Opportunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.